Skip to main content

Table 1 Percentage of ARGs co-occurring with MGEs before, during, and after antibiotic exposure

From: Oral administration of antibiotics increased the potential mobility of bacterial resistance genes in the gut of the fish Piaractus mesopotamicus

Day

Phage integrases

Transposon

Transposase

RteC

Resolvase

Total*

0

1.78 ± 0.69

0.00 ± 0.00

1.93 ± 0.53

0.20 ± 0.28

0.28 ± 0.39

4.19 ± 0.04

1

0.96 ± 0.47

0.00 ± 0.00

3.52 ± 1.00

0.00 ± 0.00

0.18 ± 0.26

4.66 ± 1.72

4

1.36 ± 0.33

0.63 ± 0.45

4.40 ± 0.83

0.19 ± 0.26

0.34 ± 0.47

6.91 ± 1.03

7

2.21 ± 0.84

1.53 ± 0.12

6.09 ± 0.31

0.00 ± 0.00

0.95 ± 0.48

10.78 ± 0.57

11

2.61 ± 2.61

0.00 ± 0.00

3.05 ± 3.05

0.00 ± 0.00

0.29 ± 0.29

5.95 ± 5.95

13

2.72 ± 1.63

0.00 ± 0.00

2.84 ± 0.83

0.41 ± 0.29

0.00 ± 0.00

5.96 ± 2.26

18

1.42 ± 0.56

0.00 ± 0.00

2.32 ± 0.76

0.00 ± 0.00

0.16 ± 0.23

3.91 ± 0.70

26

0.80 ± 0.57

0.00 ± 0.00

2.25 ± 2.09

0.19 ± 0.26

0.62 ± 0.47

3.87 ± 2.30

34

1.12 ± 1.59

0.00 ± 0.00

2.94 ± 2.52

0.00 ± 0.00

0.00 ± 0.00

4.07 ± 1.50

Control

0.93 ± 1.31

0.00 ± 0.00

0.82 ± 1.16

0.27 ± 0.38

0.40 ± 0.56

2.41 ± 1.29

  1. Days under antibiotic treatment are presented in italics. ± indicates the S.D. Control was sampled at day 34
  2. *Total includes ARGs co-occurring with more than one MGE